Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Profiling of post-mortem brain microRNA in Alzheimer’s disease

ABSTRACT: Profiling of post-mortem brain microRNA in Alzheimer’s disease

PROVIDER: PRJNA660604 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Post-mortem gene expression from mouse brain

Project description:Post-mortem gene expression from mouse brain

| PRJNA672107 | ENA

RNA-sequencing of human post-mortem brain tissues

Project description:RNA-seq profiling was conducted on clinically-annotated human post-mortem brain tissues

2017-06-22 | GSE80655 | GEO

Epigenome wide association study of post-mortem Alzheimer’s Disease samples

Project description:Epigenome wide association study of post-mortem Alzheimer’s Disease samples

| PRJNA659724 | ENA

Epigenome Analysis of Post-Mortem Human Temporal Pole Brain Tissue

Project description:Epigenome Analysis of Post-Mortem Human Temporal Pole Brain Tissue For more information, please refer to DOI: 10.3233/JAD-141989

2015-03-31 | GSE67419 | GEO

Single Nucleus Sequencing Reveals Artifactual Gene Expression and Variance in Post-Mortem Brain

Project description:Single nucleus sequencing of fresh frozen post-mortem brain

2020-12-01 | GSE157760 | GEO

Epigenome wide association study of post-mortem Alzheimer’s Disease samples

Project description:Samples from 72 AD patients and 62 age-matched cognitively normal controls were assayed using Illumina© Infinium MethylationEPIC BeadChip. We performed an epigenome-wide association study (EWAS) to evaluate the epigenetic differences using post-mortem superior temporal gyrus (STG) and inferior frontal gyrus (IFG) samples. We performed an epigenome-wide association study (EWAS) to evaluate the epigenetic differences using post-mortem superior temporal gyrus (STG) and inferior frontal gyrus (IFG) samples.

2020-10-20 | GSE156984 | GEO

Comparison of post-mortem tissue from brain BA10 region between schizophrenic and control patients.

Project description:Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Schizophrenia is a severe psychiatric disorder with a world-wide prevalence of 1%. The pathophysiology of the illness is not understood, but is thought to have a strong genetic component with some environmental influences on aetiology. To gain further insight into disease mechanism, we used microarray technology to determine the expression of over 30 000 mRNA transcripts in post-mortem tissue from a brain region associated with the pathophysiology of the disease (Brodmann area 10: anterior prefrontal cortex) in 28 schizophrenic and 23 control patients. Post-mortem derived BA10 tissue from 28 schizophrenic and 23 control patients were compared. Age, gender, post-mortem delay and pH of brain lysates data were also captured.

2009-08-13 | E-GEOD-17612 | biostudies-arrayexpress

Epigenome Analysis of Post-Mortem Human Temporal Pole Brain Tissue

Project description:Epigenome Analysis of Post-Mortem Human Temporal Pole Brain Tissue For more information, please refer to DOI: 10.3233/JAD-141989 Temporal Pole regions from 24 age-matched causcasian males: 8 samples which died of normal causes, 8 samples with Alzheimer's disease (stage 3/4) and 8 samples with dementia with lewy bodies

2015-03-31 | E-GEOD-67419 | biostudies-arrayexpress

Alzheimer’s Disease (AD) and Lewy Body Dementia (LBD): Detection of S-Nitrosylation in Key Proteins in Human, Post-mortem Brain Samples

Project description:FAD and Lewy Body Dementia (LBD): Detection of S-Nitrosylation in Key Proteins in Human, Post-mortem Brain Samples

2023-03-10 | PXD020945 | Pride

Bulk RNAseq of post-mortem brain tissue of Aicardi-Goutières Syndrome patients and non-diseased controls

Project description:Post mortem brain tissue of three Patients suffering from Aicardi-Goutières Syndrome from different brain regions was used to isolate RNA and perform RNAseq analysis compared to age matched control patients with no underlying brain pathology.

2023-12-01 | GSE162414 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data